Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
CALL
Ameriprise Financial
AMP
$50.3B
| $3.98M | ﹤0.01% |
23,500
-300
| -1% | -$48.1K |
|
|
EGRX
2602
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.98M | ﹤0.01% |
+74,469
| New | +$4.14M |
|
|
SONC
2603
DELISTED
Sonic Corp
SONC
| $3.98M | ﹤0.01% |
144,718
-322,380
| -69% | -$8.31M |
|
2604
CALL
Centene
CNC
$33.3B
| $3.98M | ﹤0.01% |
78,800
-68,800
| -47% | -$3.33M |
|
2605
CALL
PPG Industries
PPG
$25.4B
| $3.97M | ﹤0.01% |
34,000
-53,400
| -61% | -$6.16M |
|
2606
Methanex
MEOH
$4.34B
| $3.97M | ﹤0.01% |
65,578
+61,064
| +1,353% | +$3.22M |
|
2607
PUT
KraneShares CSI China Internet ETF
KWEB
$5.35B
| $3.97M | ﹤0.01% |
67,700
+59,700
| +746% | +$3.46M |
|
|
FDC
2608
PUT
DELISTED
First Data Corporation
FDC
| $3.96M | ﹤0.01% |
236,900
+148,300
| +167% | +$2.55M |
|
2609
CALL
Stellantis
STLA
$20.2B
| $3.95M | ﹤0.01% |
221,600
+74,100
| +50% | +$1.3M |
|
|
CIT
2610
PUT
DELISTED
CIT Group Inc.
CIT
| $3.95M | ﹤0.01% |
80,300
-55,500
| -41% | -$2.69M |
|
2611
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $3.95M | ﹤0.01% |
155,253
-376,260
| -71% | -$9.5M |
|
|
LKSD
2612
DELISTED
LSC Communications, Inc.
LKSD
| $3.95M | ﹤0.01% |
260,445
-18,620
| -7% | -$296K |
|
2613
CALL
ProShares Short S&P500
SH
$841M
| $3.94M | ﹤0.01% |
32,675
+17,325
| +113% | +$2.15M |
|
2614
CALL
T. Rowe Price
TROW
$23.6B
| $3.94M | ﹤0.01% |
37,500
-13,700
| -27% | -$1.34M |
|
|
BPMC
2615
PUT
DELISTED
Blueprint Medicines
BPMC
| $3.93M | ﹤0.01% |
52,100
+36,900
| +243% | +$2.6M |
|
2616
PUT
Williams Companies
WMB
$92B
| $3.92M | ﹤0.01% |
128,500
+19,200
| +18% | +$558K |
|
2617
PUT
JetBlue
JBLU
$2.13B
| $3.91M | ﹤0.01% |
175,100
-8,700
| -5% | -$178K |
|
2618
PUT
Vodafone
VOD
$37.9B
| $3.91M | ﹤0.01% |
122,600
-124,700
| -50% | -$3.74M |
|
2619
CALL
Lincoln National
LNC
$8.7B
| $3.9M | ﹤0.01% |
50,800
-18,800
| -27% | -$1.42M |
|
2620
PUT
Eagle Materials
EXP
$6.4B
| $3.9M | ﹤0.01% |
34,400
+5,500
| +19% | +$595K |
|
2621
Mueller Water Products
MWA
$3.99B
| $3.89M | ﹤0.01% |
310,658
+47,918
| +18% | +$591K |
|
2622
PUT
Dycom Industries
DY
$12.6B
| $3.89M | ﹤0.01% |
34,900
+3,700
| +12% | +$357K |
|
2623
OneSpan
OSPN
$602M
| $3.89M | ﹤0.01% |
279,754
+14,300
| +5% | +$189K |
|
2624
CALL
Trade Desk
TTD
$6.64B
| $3.88M | ﹤0.01% |
849,000
+348,000
| +69% | +$1.92M |
|
2625
Wingstop
WING
$3.44B
| $3.88M | ﹤0.01% |
99,584
+58,242
| +141% | +$2.15M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.